NCT02675855: A trial that was reported late by Osiris Therapeutics
This trial has reported, although it was 1353 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02675855 |
|---|---|
| Title | A Multicenter, Randomized, Single-Blind Study Comparing the Efficacy of GrafixPRIME® to Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2016 |
| Completion date | July 31, 2017 |
| Required reporting date | July 31, 2018, midnight |
| Actual reporting date | April 14, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 1353 |